Moexipril hydrochloride and hydrochlorothiazide
- Product NDC
- 23155-037
- 11-digit product format
- 231550037
- Labeler code
- 23155
- Product ID
- 23155-037_d4ae2984-5dd8-45d9-8a40-35ef92519e44
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Moexipril hydrochloride and hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Heritage Pharmaceuticals Inc.
- Application
- ANDA202150
- Marketing category
- ANDA
- Marketing start
- 2014-03-20
- Marketing end
- 0000-00-00
- Substance
- MOEXIPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
- Active strength
- 15 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record